nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—CYP2C9—Zileuton—asthma	0.125	0.173	CbGbCtD
Sulfisoxazole—CYP2C9—Zafirlukast—asthma	0.11	0.153	CbGbCtD
Sulfisoxazole—CYP2C9—Formoterol—asthma	0.106	0.147	CbGbCtD
Sulfisoxazole—CYP2C9—Arformoterol—asthma	0.106	0.147	CbGbCtD
Sulfisoxazole—CYP2C9—Theophylline—asthma	0.0849	0.118	CbGbCtD
Sulfisoxazole—CYP2C9—Loratadine—asthma	0.0805	0.112	CbGbCtD
Sulfisoxazole—CYP2C9—Montelukast—asthma	0.0805	0.112	CbGbCtD
Sulfisoxazole—CYP2C9—Dexamethasone—asthma	0.0278	0.0386	CbGbCtD
Sulfisoxazole—Sulfamethazine—ALB—asthma	0.000683	0.283	CrCbGaD
Sulfisoxazole—Sulfamerazine—ALB—asthma	0.000668	0.277	CrCbGaD
Sulfisoxazole—Sulfamethizole—ALB—asthma	0.000518	0.214	CrCbGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADRB2—asthma	0.000423	0.00153	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—EDNRB—asthma	0.000423	0.00153	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CSF2RB—asthma	0.000421	0.00152	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—NPS—asthma	0.000419	0.00151	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—TAC1—asthma	0.000419	0.00151	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—TACR2—asthma	0.000412	0.00149	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCR8—asthma	0.000412	0.00149	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CXCR3—asthma	0.000411	0.00148	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—asthma	0.000403	0.00146	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—CCR5—asthma	0.000395	0.00142	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—POMC—asthma	0.000394	0.00142	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PTGDR2—asthma	0.00039	0.00141	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PMCH—asthma	0.00039	0.00141	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NPSR1—asthma	0.00039	0.00141	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HRH4—asthma	0.00039	0.00141	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CCL2—asthma	0.000385	0.00139	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CSF2RB—asthma	0.000382	0.00138	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—EDN1—asthma	0.000378	0.00137	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—BDKRB2—asthma	0.000376	0.00136	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL5—asthma	0.000375	0.00135	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—TACR2—asthma	0.000374	0.00135	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCR8—asthma	0.000374	0.00135	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCL17—asthma	0.000367	0.00132	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PDE4A—asthma	0.00036	0.0013	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PLA2G4A—asthma	0.000349	0.00126	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—asthma	0.000348	0.00126	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—KNG1—asthma	0.000342	0.00123	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—AGTR1—asthma	0.00034	0.00123	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR5—asthma	0.000338	0.00122	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CYSLTR1—asthma	0.000337	0.00122	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CXCL10—asthma	0.000332	0.0012	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—C3—asthma	0.00033	0.00119	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PDE4A—asthma	0.000327	0.00118	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—VIP—asthma	0.000326	0.00118	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—C5AR1—asthma	0.000326	0.00118	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—UTS2—asthma	0.000326	0.00118	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—ADRB2—asthma	0.000322	0.00116	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCR4—asthma	0.000312	0.00113	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CYSLTR1—asthma	0.000306	0.00111	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CXCL8—asthma	0.000305	0.0011	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL2RB—asthma	0.000301	0.00109	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PDE4D—asthma	0.000298	0.00108	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—VIP—asthma	0.000296	0.00107	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCL11—asthma	0.000296	0.00107	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—C5AR1—asthma	0.000296	0.00107	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—UTS2—asthma	0.000296	0.00107	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FCER2—asthma	0.000292	0.00105	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—C3AR1—asthma	0.000292	0.00105	CbGpPWpGaD
Sulfisoxazole—Sulfamethoxazole—ALB—asthma	0.000291	0.12	CrCbGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PDE4B—asthma	0.00029	0.00105	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—C5—asthma	0.00029	0.00105	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—TACR1—asthma	0.00029	0.00105	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—EDN1—asthma	0.000288	0.00104	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCL5—asthma	0.000286	0.00103	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCR4—asthma	0.000284	0.00102	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CYSLTR2—asthma	0.000281	0.00101	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL2RB—asthma	0.000273	0.000986	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL22—asthma	0.000271	0.000979	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LTB4R—asthma	0.000271	0.000979	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTGDR—asthma	0.000271	0.000979	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PDE4D—asthma	0.000271	0.000977	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCR3—asthma	0.000266	0.000959	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	0.000264	0.000954	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PDE4B—asthma	0.000264	0.000952	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—C5—asthma	0.000264	0.000952	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—TACR1—asthma	0.000264	0.000952	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—NPY—asthma	0.000259	0.000934	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	0.000259	0.000933	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCR5—asthma	0.000257	0.000929	CbGpPWpGaD
Sulfisoxazole—Dapsone—PTGS2—asthma	0.000255	0.106	CrCbGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—C3—asthma	0.000252	0.000908	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AGTR2—asthma	0.00025	0.000901	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCR3—asthma	0.000241	0.000871	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—EDNRB—asthma	0.000239	0.000863	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—NPS—asthma	0.000237	0.000854	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—TAC1—asthma	0.000237	0.000854	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NPY—asthma	0.000235	0.000848	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCR3—asthma	0.000232	0.000838	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTGDR2—asthma	0.000231	0.000832	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HRH4—asthma	0.000231	0.000832	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NPSR1—asthma	0.000231	0.000832	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PMCH—asthma	0.000231	0.000832	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AGTR2—asthma	0.000227	0.000819	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CSF2RB—asthma	0.000226	0.000815	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR8—asthma	0.000221	0.000798	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TACR2—asthma	0.000221	0.000798	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL5—asthma	0.00022	0.000794	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—EDNRB—asthma	0.000217	0.000784	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL17—asthma	0.000217	0.000783	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—TAC1—asthma	0.000215	0.000776	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NPS—asthma	0.000215	0.000776	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—ALDH2—asthma	0.000214	0.000774	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—asthma	0.000213	0.000769	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—BDKRB2—asthma	0.000212	0.000766	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCR3—asthma	0.000211	0.000761	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—ADCY2—asthma	0.000205	0.000742	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL3—asthma	0.000205	0.000739	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	0.000204	0.000738	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTT1—asthma	0.000204	0.000736	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—asthma	0.000202	0.000728	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—POMC—asthma	0.000201	0.000726	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL5—asthma	0.0002	0.000721	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCL2—asthma	0.000197	0.000711	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PTGS2—asthma	0.000197	0.00071	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LTC4S—asthma	0.000194	0.000702	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KIF3A—asthma	0.000193	0.000698	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDE4A—asthma	0.000193	0.000698	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—KNG1—asthma	0.000193	0.000697	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—BDKRB2—asthma	0.000193	0.000696	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AGTR1—asthma	0.000192	0.000693	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCL10—asthma	0.000188	0.000677	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ADCY2—asthma	0.000187	0.000673	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL3—asthma	0.000186	0.000671	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—ADRB2—asthma	0.000182	0.000658	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CYSLTR1—asthma	0.000181	0.000653	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—KNG1—asthma	0.000175	0.000633	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CMA1—asthma	0.000175	0.000631	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—C5AR1—asthma	0.000175	0.000631	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VIP—asthma	0.000175	0.000631	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—UTS2—asthma	0.000175	0.000631	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL11—asthma	0.000175	0.000631	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AGTR1—asthma	0.000174	0.000629	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—asthma	0.000173	0.000624	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—ITPR1—asthma	0.000172	0.000622	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCL10—asthma	0.00017	0.000615	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LTA4H—asthma	0.000169	0.000608	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR4—asthma	0.000168	0.000605	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ADRB2—asthma	0.000165	0.000597	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STAT6—asthma	0.000164	0.000593	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—EDN1—asthma	0.000163	0.000588	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCL5—asthma	0.000161	0.000583	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL2RB—asthma	0.000161	0.000582	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDE4D—asthma	0.00016	0.000577	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CSF2—asthma	0.000159	0.000574	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ITPR1—asthma	0.000156	0.000565	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDE4B—asthma	0.000156	0.000562	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—C5—asthma	0.000156	0.000562	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TACR1—asthma	0.000156	0.000562	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CXCL8—asthma	0.000156	0.000562	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	0.000155	0.00056	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—EDN1—asthma	0.000148	0.000534	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCL5—asthma	0.000147	0.000529	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PLA2G4A—asthma	0.000146	0.000527	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCR5—asthma	0.000145	0.000525	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CSF2—asthma	0.000144	0.000522	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL2RA—asthma	0.000143	0.000518	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR3—asthma	0.000142	0.000514	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—C3—asthma	0.000142	0.000513	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTP1—asthma	0.000141	0.00051	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTP1—asthma	0.000139	0.000503	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NPY—asthma	0.000139	0.000501	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PPP2CA—asthma	0.000135	0.000486	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AGTR2—asthma	0.000134	0.000484	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCR5—asthma	0.000132	0.000477	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL2RA—asthma	0.00013	0.00047	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTM1—asthma	0.00013	0.000469	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—C3—asthma	0.000129	0.000466	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EDNRB—asthma	0.000128	0.000463	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTM1—asthma	0.000128	0.000462	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NPS—asthma	0.000127	0.000458	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TAC1—asthma	0.000127	0.000458	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCR3—asthma	0.000125	0.00045	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CYBA—asthma	0.000121	0.000435	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL5—asthma	0.000118	0.000426	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PARP1—asthma	0.000118	0.000426	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BDKRB2—asthma	0.000114	0.000411	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—POMC—asthma	0.000114	0.000411	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADCY2—asthma	0.00011	0.000398	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL3—asthma	0.00011	0.000396	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	0.000106	0.000382	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—asthma	0.000106	0.000382	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KNG1—asthma	0.000104	0.000374	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—POMC—asthma	0.000103	0.000373	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AGTR1—asthma	0.000103	0.000372	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCL2—asthma	0.000101	0.000365	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—asthma	0.000101	0.000364	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6R—asthma	0.000101	0.000364	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL10—asthma	0.000101	0.000363	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—RHOA—asthma	0.0001	0.000362	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NTRK1—asthma	9.87e-05	0.000356	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADRB2—asthma	9.77e-05	0.000353	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ITPR1—asthma	9.24e-05	0.000334	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—POMC—asthma	9.18e-05	0.000331	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—RHOA—asthma	9.1e-05	0.000328	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—asthma	9e-05	0.000325	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CD86—asthma	8.8e-05	0.000318	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCL8—asthma	8.8e-05	0.000318	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EDN1—asthma	8.73e-05	0.000315	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL5—asthma	8.66e-05	0.000313	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LTC4S—asthma	8.66e-05	0.000312	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PLA2G4A—asthma	8.63e-05	0.000312	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—asthma	8.58e-05	0.00031	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CSF2—asthma	8.53e-05	0.000308	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL2—asthma	8.41e-05	0.000303	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SMAD3—asthma	8.31e-05	0.0003	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCL8—asthma	7.99e-05	0.000288	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PPP2CA—asthma	7.95e-05	0.000287	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR5—asthma	7.8e-05	0.000282	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL2RA—asthma	7.69e-05	0.000278	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL2—asthma	7.63e-05	0.000276	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—C3—asthma	7.63e-05	0.000275	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LTA4H—asthma	7.5e-05	0.000271	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDGFB—asthma	7.42e-05	0.000268	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LEP—asthma	7.1e-05	0.000256	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FN1—asthma	6.7e-05	0.000242	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ARG1—asthma	6.56e-05	0.000237	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—POMC—asthma	6.1e-05	0.00022	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL2—asthma	5.97e-05	0.000215	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6R—asthma	5.95e-05	0.000215	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALDH7A1—asthma	5.93e-05	0.000214	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—EGFR—asthma	5.84e-05	0.000211	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ARG2—asthma	5.69e-05	0.000205	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SERPINE1—asthma	5.57e-05	0.000201	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RHOA—asthma	5.37e-05	0.000194	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOS3—asthma	5.32e-05	0.000192	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	4.99e-05	0.00018	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL8—asthma	4.72e-05	0.00017	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALOX5AP—asthma	4.71e-05	0.00017	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALOX15—asthma	4.71e-05	0.00017	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL2—asthma	4.51e-05	0.000163	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CHAT—asthma	4.5e-05	0.000162	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6—asthma	4.49e-05	0.000162	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MMP9—asthma	4.27e-05	0.000154	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTEN—asthma	4.24e-05	0.000153	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALOX5—asthma	4.01e-05	0.000145	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VEGFA—asthma	3.83e-05	0.000138	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CARM1—asthma	3.82e-05	0.000138	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STAT3—asthma	3.79e-05	0.000137	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—DCN—asthma	3.77e-05	0.000136	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALDH2—asthma	3.66e-05	0.000132	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	3.52e-05	0.000127	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TGFB1—asthma	3.52e-05	0.000127	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTT1—asthma	3.49e-05	0.000126	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EGFR—asthma	3.45e-05	0.000125	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	3.21e-05	0.000116	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NQO1—asthma	2.9e-05	0.000105	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ADCY2—asthma	2.84e-05	0.000102	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.81e-05	0.000101	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6—asthma	2.65e-05	9.57e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	2.45e-05	8.85e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTP1—asthma	2.42e-05	8.72e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HMOX1—asthma	2.38e-05	8.6e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ITPR1—asthma	2.38e-05	8.58e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CAT—asthma	2.35e-05	8.49e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLA2G4A—asthma	2.22e-05	8.02e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTM1—asthma	2.22e-05	8.02e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPP2CA—asthma	2.04e-05	7.38e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—POMC—asthma	1.57e-05	5.67e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALB—asthma	1.43e-05	5.17e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NOS3—asthma	1.37e-05	4.94e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS2—asthma	1.25e-05	4.52e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTEN—asthma	1.09e-05	3.94e-05	CbGpPWpGaD
